Effect of Blueberry Supplementation on a Diet-Induced Rat Model of Prediabetes—Focus on Hepatic Lipid Deposition, Endoplasmic Stress Response and Autophagy

Gonçalo Ferreira,Pedro Vieira,André Alves,Sara Nunes,Inês Preguiça,Tânia Martins-Marques,Tânia Ribeiro,Henrique Girão,Artur Figueirinha,Lígia Salgueiro,Manuela Pintado,Pedro Gomes,Sofia Viana,Flávio Reis

DOI: https://doi.org/10.3390/nu16040513

IF: 5.9

2024-02-14

Nutrients

Abstract:Blueberries, red fruits enriched in polyphenols and fibers, are envisaged as a promising nutraceutical intervention in a plethora of metabolic diseases. Prediabetes, an intermediate state between normal glucose tolerance and type 2 diabetes, fuels the development of complications, including hepatic steatosis. In previous work, we have demonstrated that blueberry juice (BJ) supplementation benefits glycemic control and lipid profile, which was accompanied by an amelioration of hepatic mitochondrial bioenergetics. The purpose of this study is to clarify the impact of long-term BJ nutraceutical intervention on cellular mechanisms that govern hepatic lipid homeostasis, namely autophagy and endoplasmic reticulum (ER) stress, in a rat model of prediabetes. Two groups of male Wistar rats, 8-weeks old, were fed a prediabetes-inducing high-fat diet (HFD) and one group was fed a control diet (CD). From the timepoint where the prediabetic phenotype was achieved (week 16) until the end of the study (week 24), one of the HFD-fed groups was daily orally supplemented with 25 g/kg body weight (BW) of BJ (HFD + BJ). BW, caloric intake, glucose tolerance and insulin sensitivity were monitored throughout the study. The serum and hepatic lipid contents were quantified. Liver and interscapular brown and epidydimal white adipose tissue depots (iBAT and eWAT) were collected for histological analysis and to assess thermogenesis, ER stress and autophagy markers. The gut microbiota composition and the short-chain fatty acids (SCFAs) content were determined in colon fecal samples. BJ supplementation positively impacted glycemic control but was unable to prevent obesity and adiposity. BJ-treated animals presented a reduction in fecal SCFAs, increased markers of arrested iBAT thermogenesis and energy expenditure, together with an aggravation of HFD-induced lipotoxicity and hepatic steatosis, which were accompanied by the inhibition of autophagy and ER stress responses in the liver. In conclusion, despite the improvement of glucose tolerance, BJ supplementation promoted a major impact on lipid management mechanisms at liver and AT levels in prediabetic animals, which might affect disease course.

nutrition & dietetics

What problem does this paper attempt to address?

This paper aims to explore the effects of blueberry supplements on liver lipid deposition, endoplasmic reticulum stress response and autophagy mechanisms in a pre - diabetic rat model induced by a high - fat diet. Specifically, the study focuses on how long - term intake of blueberry juice (BJ) as a nutritional intervention affects the regulatory mechanisms of liver lipid homeostasis in pre - diabetic rats, especially autophagy and endoplasmic reticulum stress response. The study evaluates its effects by observing the changes in body weight, caloric intake, glucose tolerance and insulin sensitivity in rats, as well as the changes in serum and liver lipid contents after blueberry juice supplementation. In addition, liver, mesenchymal brown adipose tissue (iBAT) and epididymal white adipose tissue (eWAT) samples were collected for histological analysis to evaluate the changes in thermogenesis, endoplasmic reticulum stress and autophagy markers. Meanwhile, the study also analyzed the changes in gut microbiome composition and short - chain fatty acid (SCFAs) content.

Through these experimental designs, researchers hope to reveal the specific effects of blueberry supplements on liver lipid metabolism mechanisms under pre - diabetic conditions, thereby providing a scientific basis for further understanding the potential roles of blueberries and their components in preventing or treating metabolic diseases.